| 63 / Vnitř Lék. 2023;69(1):57-63 / VNITŘNÍ LÉKAŘSTVÍ www.casopisvnitrnilekarstvi.cz CO JE NOVÉHO V… Novinky v kardiologii 2022 LITERATURA 1. Castellano JM, Pocock SJ, Bhatt DL, et al. SECURE Investigators. Polypill Strategy in Se‑ condary Cardiovascular Prevention. N Engl J Med. 2022 Sep 15;387(11):967-977. 2. Mackenzie IS, Rogers A, Poulter NR, et al. Lancet. 2022 Oct 22;400(10361):1417-1425. 3. Tita AT, Szychowski JM, Boggess K, et al. Chronic Hypertension and Pregnancy (CHAP) Trial Consortium. Treatment for Mild Chronic Hypertension during Pregnancy. N Engl J Med. 2022 May 12;386(19):1781-1792. 4. Halvorsen S, Mehilli J, Cassese S, et al. 2022 ESC Guidelines on cardiovascular asse‑ ssment and management of patients undergoing non‑cardiac surgery. Eur Heart J. 2022 Oct 14;43(39):3826-3924. 5. Kjaergaard J, Møller JE, Schmidt H, et al. Blood‑Pressure Targets in Comatose Survivors of Cardiac Arrest. N Engl J Med. 2022 Oct 20;387(16):1456-1466. 6. Schmidt H, Kjaergaard J, Hassager C, et al. Oxygen Targets in Comatose Survivors of Car‑ diac Arrest. N Engl J Med. 2022 Oct 20;387(16):1467-1476. 7. Solomon SD, McMurray JJV, Claggett B, et al. DELIVER Trial Committees and Investiga‑ tors. Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction. N Engl J Med. 2022 Sep 22;387(12):1089-1098. 8. Ezekowitz JA, Colin‑Ramirez E, Ross H, et al. SODIUM‑HF Investigators. Reduction of di‑ etary sodium to less than 100 mmol in heart failure (SODIUM‑HF): an international, open ‑label, randomised, controlled trial. Lancet. 2022 Apr 9;399(10333):1391-1400. Erratum in: Lancet. 2022 Oct 8;400(10359):1194. 9. Mebazaa A, Davison B, Chioncel O, et al. Safety, tolerability and efficacy of up‑titration of guideline‑directed medical therapies for acute heart failure (STRONG‑HF): a multinati‑ onal, open‑label, randomised, trial. Lancet. 2022 Dec 3;400(10367):1938-1952. 10. Ishani A, Cushman WC, Leatherman SM, et al. Diuretic Comparison Project Writing Group. Chlorthalidone vs. Hydrochlorothiazide for Hypertension‑Cardiovascular Events. N Engl J Med. 2022 Dec 29;387(26):2401-2410. PŘEDNÁŠKY Léčba hypertenze v roce 2022? Cílem je snížit riziko kardiovaskulární příhody! – MUDr. Petra Vysočanová Dušnost – MUDr. Marek Šramko, Ph.D. Bolest na hrudi – doc. MUDr. Jiří Kettner, CSc. Palpitace – prof. MUDr. Josef Kautzner, CSc., FESC Synkopy – MUDr. Jana Hašková ODBORNÝ GARANT MUDr. Petra Vysočanová Fakultní nemocnice Brno-Bohunice, Interní kardiologická klinika PARTNER POČET KREDITŮ 2 Registrace ZDARMA TERMÍN květen 2022 až květen 2023 dostupný na online.solen.cz On-line kurz Kardiovaskulární onemocnění 2 ON LINE KURZ KONTAKT: Mgr. Vendula Pávková +420 777 714 679 | pavkova@solen.cz
RkJQdWJsaXNoZXIy NDA4Mjc=